“First-Of-A-Kind” Aerocrine NIOX Nitric Oxide Asthma Test Gets FDA Nod
This article was originally published in The Gray Sheet
Executive Summary
Aerocrine's NIOX asthma monitoring test will allow physicians to closely evaluate the efficacy of asthma therapy in a non-invasive manner, following FDA 510(k) clearance, announced May 1